Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences, Poznan, Poland.
Physiol Res. 2013;62(6):663-70. doi: 10.33549/physiolres.932509. Epub 2013 Jul 17.
Rats with diabetes induced by streptozotocin (STZ) and nicotinamide (NA) are often used in animal studies concerning various aspects of diabetes. In this experimental model, the severity of diabetes is different depending on doses of STZ and NA. Moreover, diabetic changes in rats with STZ-NA-induced diabetes are not fully characterized. In our present study, metabolic changes and insulin secretion were investigated in rats with diabetes induced by administration of 60 mg of STZ and 90 mg of NA per kg body weight. Four to six weeks after diabetes induction, insulin, glucagon and some metabolic parameters were determined to evaluate the severity of diabetes. Moreover, insulin secretory capacity of pancreatic islets isolated from control and diabetic rats was compared. It was demonstrated that administration of 60 mg of STZ and 90 mg of NA per kg body weight induced relatively mild diabetes, since insulin, glucagon and other analyzed parameters were only slightly affected in diabetic rats compared with control animals. In vitro studies revealed that insulin secretory response was preserved in pancreatic islets of diabetic rats, however, was lower than in islets of control animals. This effect was observed in the presence of different stimuli. Insulin secretion induced by 6.7 and 16.7 mmol/l glucose was moderately reduced in islets of diabetic rats compared with control islets. In the presence of leucine with glutamine, insulin secretion appeared to be also decreased in islets of rats with STZ-NA-induced diabetes. Insulinotropic action of 6.7 mmol/l glucose with forskolin was also deteriorated in diabetic islets. Moreover, it was demonstrated that at a non-stimulatory glucose, pharmacological depolarization of plasma membrane with a concomitant activation of protein kinase C evoked significant rise in insulin release in islets of control and diabetic rats. However, in diabetic islets, this effect was attenuated. These results indicate that impairment in insulin secretion in pancreatic islets of rats with mild diabetes induced by STZ and NA results from both metabolic and nonmetabolic disturbances in these islets.
链脲佐菌素(STZ)和烟酰胺(NA)诱导的糖尿病大鼠常用于各种糖尿病相关方面的动物研究。在该实验模型中,STZ 和 NA 的剂量不同,糖尿病的严重程度也不同。此外,STZ-NA 诱导的糖尿病大鼠的糖尿病变化尚未完全表征。在本研究中,我们研究了给予 60mg STZ 和 90mg NA/kg 体重诱导的糖尿病大鼠的代谢变化和胰岛素分泌。糖尿病诱导 4 至 6 周后,测定胰岛素、胰高血糖素和一些代谢参数以评估糖尿病的严重程度。此外,比较了来自对照组和糖尿病大鼠的胰岛的胰岛素分泌能力。结果表明,给予 60mg STZ 和 90mg NA/kg 体重诱导的糖尿病相对较轻,因为与对照组动物相比,糖尿病大鼠的胰岛素、胰高血糖素和其他分析参数仅受到轻微影响。体外研究表明,在糖尿病大鼠的胰岛中,胰岛素分泌反应得以保留,但低于对照组胰岛。这种作用在不同刺激物存在的情况下观察到。与对照组胰岛相比,糖尿病大鼠胰岛中 6.7 和 16.7mmol/L 葡萄糖诱导的胰岛素分泌适度减少。在亮氨酸加谷氨酰胺存在的情况下,STZ-NA 诱导的糖尿病大鼠胰岛中的胰岛素分泌似乎也减少。6.7mmol/L 葡萄糖加 forskolin 的胰岛素促分泌作用在糖尿病胰岛中也恶化。此外,还证明了在非刺激葡萄糖存在下,通过药理学去极化质膜并同时激活蛋白激酶 C,可引起对照组和糖尿病大鼠胰岛中胰岛素释放的显著增加。然而,在糖尿病胰岛中,这种作用被减弱。这些结果表明,STZ 和 NA 诱导的轻度糖尿病大鼠胰岛中胰岛素分泌受损是由于这些胰岛中的代谢和非代谢紊乱所致。